OnKure Therapeutics, Inc. (OKUR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.94M | -11.51M | -13.04M | -13.27M | -14.01M | -21.02M | -10.66M | -6.47M | -10.63M | 9.38M | -18.77M | -11.09M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 7.62% | 45.22% | -22.29% | -105.07% | -31.76% | -323.97% | 43.19% | 41.65% | - | - | - | - |
| Net Income | -15.16M | -13.5M | -14.7M | -15.39M | -15.93M | -35.19M | -11.56M | -14.14M | -9.54M | 18.52M | -19.2M | -8.18M |
| Depreciation & Amortization | 203K | 202K | 204K | 212K | 212K | 622K | 155K | 148K | 151K | 434K | 43K | 155K |
| Stock-Based Compensation | 2.78M | 3.02M | 2.96M | 2.91M | 2.75M | 1.64M | 77K | 1.81M | 107K | -3.59M | 0 | 17K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -764K | 4K | 2K | 0 | 0 | 2.06M | 127K | 1K | 0 | 2.15M | 197K | 1K |
| Working Capital Changes | 0 | -1.23M | -1.5M | -1M | -1.04M | 9.86M | 536K | 5.7M | -1.35M | -8.13M | 189K | -3.08M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -905K | -305K | 0 | -1.2M | -1.68M | 10.96M | 0 | 0 | -1.74M | -4.79M | -183K | 0 |
| Cash from Investing | -5K | -9K | -6K | -13K | -18K | -45.38M | -18K | -10K | -9K | 29.01M | 21.25M | -60K |
| Capital Expenditures | -5K | -9K | -6K | -13K | -18K | -50K | -18K | -10K | -9K | -50K | -19K | -60K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 146M | 240K | 0 | 0 | -77K | 114.22M | 5K | 5.87M | 10K | -11.87M | 173K | -2K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 240K | 0 | 0 | -37K | 58.91M | 5K | 10K | 10K | -64.93M | 173K | 6K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 146M | 0 | 0 | 0 | -40K | 55.31M | 0 | 5.86M | 0 | 53.06M | 0 | -8K |
| Net Change in Cash | 133.06M | -11.28M | -13.04M | -13.29M | -14.1M | 50.07M | -10.67M | -615K | -10.63M | 18.14M | 2.66M | -11.15M |
| Free Cash Flow | -12.94M | -11.52M | -13.04M | -13.29M | -14.02M | -21.07M | -10.68M | -6.48M | -10.64M | 9.33M | -18.79M | -11.15M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 7.7% | 45.31% | -22.14% | -104.95% | -31.82% | -325.7% | 43.15% | 41.87% | - | - | - | - |
| FCF per Share | -0.95 | -0.85 | -0.97 | -0.98 | -1.04 | -1.58 | -0.80 | -0.49 | -0.80 | 0.70 | -1.41 | -0.84 |
| FCF Conversion (FCF/Net Income) | - | 0.85x | 0.89x | 0.86x | 0.88x | 0.60x | 2.89x | 0.46x | 1.11x | 0.51x | 0.98x | 1.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |